BCL2 and benign prostatic hyperplasia: On the other hand, the anti-apoptotic markers Bcl-2 and Bcl-XL are elevated in BPH but significantly reduced by HCQ or FIN, with the combination showing a stronger effect (Fig. 3C and D).